Home > PJ (current issue)> Vision for pharmacy

PJ Online homeThe Pharmaceutical Journal
Vol 272 No 7289 p286
6 March 2004

This article
Reprint
Photocopy

 

PDF* 40K

Vision for pharmacy

Smoking cessation voucher scheme involves the whole pharmacy team

The Department of Health’s “Vision for pharmacy” document comments that people are increasingly looking to their local pharmacist for advice on stopping smoking. Recent developments in Manchester illustrate how the profession is responding to this demand. Joanna Lumb reports

Vision for pharmacy series  |  No Smoking Day links


Over the past six months there has been a 28 per cent increase in the number of pharmacy staff who are trained as intermediate level smoking cessation advisers. In September 2003, there were 49 trained advisers among the 110 pharmacies in the three Manchester PCTs. There are now 63 pharmacy advisers.

One of the pharmacists involved is Paul Benson. At his pharmacy in Chorlton-cum-Hardy, two pharmacists and one of the medicines counter assistants are trained advisers. They take part in a voucher scheme designed to increase access to nicotine replacement therapy. Accredited advisers can write these vouchers, as well as redeem vouchers written by other advisers (eg, practice nurses) or by staff at specialist centres.

The PCT-funded scheme, which is organised by the specialist smoking cessation service of Manchester Health Promotion, allows up to six weeks’ supply of NRT. Supply is free for prescription-exempt customers or £6.30 for each fortnight’s supply for non-exempt customers.

Mr Benson does not advertise his smoking cessation service, other than in occasional window displays. Clients are recruited into the scheme by self-referral or referral from the GP or practice nurse. Staff might also pick up on cues, eg, purchase of a cough medicine, to ask if the customer smokes and has thought about stopping. But he is cautious about this approach: “We tread softly here as we don’t want to alienate people by haranguing them. It is better to wait for them to raise the issue.”

The first interview involves an assessment of whether the person is motivated to make a serious attempt to stop smoking. “We make a judgement on this, but tend to give them the benefit of the doubt,” Mr Benson says. Clients are given advice on smoking cessation and are asked to set a quit date.

Any of the P or GSL products can be supplied. Clients choose which formulation they prefer, and the pharmacist will advise on the product strength, based on an assessment of nicotine dependence. The pharmacy has a consultation room but this is not often used, since most people are happy to talk in a quiet area of the pharmacy. The first session takes at least 10 minutes, but subsequent visits are shorter. For the first two weeks, supply is made on a weekly basis, then fortnightly. After four weeks, smoking status is recorded. This is needed for central statistics.

Mr Benson emphasises that the whole pharmacy team can be involved. “A counter assistant or technician who has received basic in-house training on how to ask questions can do the initial paperwork, before handing over to one of the trained advisers. This is a sensible use of available staff.”

Counter assistant Joyce Mills recently undertook training as a smoking cessation adviser

He is pleased that one of his counter assistants, Joyce Mills, recently undertook training as a smoking cessation adviser: she had been doing much of the documentation and it was a natural next step for her to take. Mrs Mills can now participate in all aspects of the service, unless the client wishes to use nicotine inhalator (a pharmacy medicine) in which case the pharmacist will become involved.

From the start, clients are advised that they might need to carry on with NRT after their six-week NHS supply. Mr Benson comments: “We encourage them to put aside the money they would have spent on cigarettes — both to buy themselves a treat and also to ensure they will be able to afford NRT and don’t undo all the good work by stopping too soon.”

It is, he says, essential to encourage people to report back, whether or not they have been successful. Relapse is common and people need support to try again. “I think this is where pharmacy scores above surgeries. Given the easy access, clients are more likely to come back to the pharmacy than make an appointment to go back to the GP.” There has been no formal survey of user satisfaction but Mr Benson says that clients are positive about the help they get and that the service definitely shows pharmacy in a favourable light.

Limitations to the scheme

There are, however, some limitations to the pharmacy voucher service. The pharmacy advisers cannot write NRT vouchers for under-18s or pregnant women. (These groups can receive NRT from specialist clinics.) Also, the pharmacists have been advised that supply to clients with coronary heart disease should first be approved by the GP. Mr Benson finds this disappointing, given that NRT is safer than continued smoking. “It is a barrier, as the client might lose motivation if they are asked to take a form to the GP before they can start on the pharmacy scheme.”

Combination therapy is another issue. “Some people might benefit from use of a patch to give background nicotine level plus a quick-acting formulation for breakthrough cravings. At the moment, I supply combination therapy if requested on a voucher from a specialist centre but I don’t initiate it.”

All these issues are currently being discussed, with a view to developing pharmacy protocols to allow supply.

On average, Mr Benson’s pharmacy enrols one new client each day. The pharmacy receives £6 per client, plus £13 payment (less any patient contribution) for each week of NRT supplied. The voucher scheme has been running for around four years and now has recurrent funding. The latest data for Manchester pharmacies, covering July to September 2003, show a 36 per cent success rate (four-week cessation) among the 266 clients. Encouragingly, unofficial data indicate that the recent increase in number of pharmacies taking part has been associated with a significant increase in clients.

For the future, Mr Benson sees new opportunities when medicines management and medication review schemes get under way. “We will be spending more time with patients with CHD and diabetes, some of whom will inevitably still be smokers, and we will be able to steer them towards the smoking cessation scheme.”


  * PDF files on PJ Online require Acrobat Reader 4 or later

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal